Sam Holliday
Directeur Général chez Oshi Health, Inc.
Profil
Sam Holliday is currently the Chief Executive Officer at Oshi Health, Inc. He previously worked as the Vice President-Prime Research at Greenway Health, Inc. He received an undergraduate degree and an MBA from the University of Pennsylvania.
Postes actifs de Sam Holliday
| Sociétés | Poste | Début |
|---|---|---|
Oshi Health, Inc.
 Oshi Health, Inc. Packaged SoftwareTechnology Services Oshi Health, Inc. engages in the provision of management and treatment of inflammatory bowel disease. It offers an IBD tracking application that uncovers the hidden patterns that allows to figure out what triggers the flares. The company was founded in 2018 and is headquartered in New York, NY. | Directeur Général | 01/12/2019 |
Anciens postes connus de Sam Holliday
| Sociétés | Poste | Fin |
|---|---|---|
Greenway Health, Inc.
 Greenway Health, Inc. Information Technology ServicesTechnology Services Greenway Health, Inc. provides technical solutions and services for healthcare customers. It offers electronic healthcare record, practice management, and clearinghouse services. The company was founded by Thomas W. Green Jr. in 1989 and is headquartered in Tampa, FL. | Corporate Officer/Principal | - |
Formation de Sam Holliday
| University of Pennsylvania | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Greenway Health, Inc.
Greenway Health, Inc. Information Technology ServicesTechnology Services Greenway Health, Inc. provides technical solutions and services for healthcare customers. It offers electronic healthcare record, practice management, and clearinghouse services. The company was founded by Thomas W. Green Jr. in 1989 and is headquartered in Tampa, FL. | Technology Services |
Oshi Health, Inc.
Oshi Health, Inc. Packaged SoftwareTechnology Services Oshi Health, Inc. engages in the provision of management and treatment of inflammatory bowel disease. It offers an IBD tracking application that uncovers the hidden patterns that allows to figure out what triggers the flares. The company was founded in 2018 and is headquartered in New York, NY. | Technology Services |
